BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10

• Press Releases

  AbTherx Appoints Abhi Saharia, PhD, as Chief Business Officer

  September 9, 2025

   · 

  2 min read
• Press Releases

  Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer

  September 9, 2025

   · 

  21 min read
• Press Releases

  New Data at American Foregut Society’s 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

  September 9, 2025

   · 

  6 min read
• Press Releases

  Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025

  September 9, 2025

   · 

  7 min read
• Press Releases

  Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

  September 9, 2025

   · 

  5 min read
• Press Releases

  Health Canada Approves Bylvay™ (odevixibat) for the treatment of cholestatic pruritus in patients with Alagille Syndrome

  September 9, 2025

   · 

  6 min read
• Press Releases

  Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

  September 9, 2025

   · 

  3 min read
• Press Releases

  FDA Grants Fast Track Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

  September 9, 2025

   · 

  2 min read
• Press Releases

  Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum

  September 9, 2025

   · 

  1 min read
• Press Releases

  Abdera Therapeutics Presents Initial Phase 1 Clinical Data on ABD-147, a Next-generation DLL3-targeting Radiopharmaceutical Therapy, at IASLC 2025 World Conference on Lung Cancer

  September 9, 2025

   · 

  6 min read